Physician profile
Devika Kir
NPI 1023466414
$10,772.90
in general payments reported to CMS, 2019-2025
20 companies · $1,616 in 2025
The $1,616 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.11 · 2020: $125 · 2021: $722 · 2022: $3,274 · 2023: $2,351 · 2024: $2,662 · 2025: $1,616.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,316 · Travel and Lodging: $3,312 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,315.80 |
| Travel and Lodging | $3,312.01 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $3,673.38 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal, Evoque |
| Medtronic, INC. | $1,510.50 | 2021-2025 | Turbohawk, Onyx Frontier, Corevalve Evolut R |
| Philips North America LLC | $1,140.81 | 2023 | |
| Inari Medical, INC. | $928.60 | 2021-2022 | |
| Abbott Laboratories | $766.31 | 2021-2025 | Cardiomems |
| Boston Scientific Corporation | $495.01 | 2022-2025 | Watchman Flx, Watchman, Rotapro |
| Cardiovascular Systems INC. | $410.85 | 2022 | |
| Davol INC. | $278.18 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $249.60 | 2021-2022 | |
| Penumbra, INC. | $210.65 | 2022-2023 | Indigo System |
| Abiomed | $204.30 | 2023-2024 | Impella |
| Impulse Dynamics (USA) INC. | $143.79 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $124.89 | 2022 | |
| Shockwave Medical, INC | $105.17 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $103.95 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $100.21 | 2022 | |
| Chiesi USA, INC. | $79.02 | 2022 | |
| Amarin Pharma, INC. | $57.32 | 2022 | |
| Asahi Intecc USA, INC. | $22.89 | 2023 | Asahi Ptca Guide Wire |
| Janssen Pharmaceuticals, INC | $19.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devika Kir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.